Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome

INTRODUCTION: Virtually all individuals with Down syndrome (DS) will develop Alzheimer's disease (AD) pathology by age 40. Cerebrospinal fluid (CSF) biomarkers have characterized AD pathology in cohorts of late‐onset AD (LOAD) and autosomal‐dominant AD (ADAD). Few studies have evaluated such bi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement (Amst)
Autors principals: Henson, Rachel L., Doran, Eric, Christian, Bradley T., Handen, Benjamin L., Klunk, William E., Lai, Florence, Lee, Joseph H., Rosas, H. Diana, Schupf, Nicole, Zaman, Shahid H., Lott, Ira T., Fagan, Anne M.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Diagnostic Assessment & Prognosis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7346867/
https://ncbi.nlm.nih.gov/pubmed/32671183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12057
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars